关注
E. Elif ÖZKAN
E. Elif ÖZKAN
在 sdu.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory …
EE Ozkan
Molecular and cellular endocrinology 344 (1-2), 1-24, 2011
792011
A case of renal synovial sarcoma treated with adjuvant ifosfamide and doxorubicin
EE Ozkan, H Mertsoylu, HI Ozardali
Internal Medicine 50 (15), 1575-1580, 2011
352011
A case report of benign schwannoma of the liver
EE Ozkan, ME Guldur, A Uzunkoy
Internal Medicine 49 (15), 1533-1536, 2010
242010
Radiotherapy for gastrointestinal stromal tumors
EE Ozkan
Chinese medical journal 131 (2), 235-240, 2018
172018
Predictive value of immune‐inflammation indices in metabolic response and outcome after curative radiotherapy in patients with non‐small cell lung cancer
EE Ozkan, ZA Kaymak Cerkesli, M Erdogan
The Clinical Respiratory Journal 14 (9), 849-856, 2020
152020
The effect of ionizing radiation on properties of fluoride-releasing restorative materials
M Ugurlu, EE Ozkan, A Ozseven
Brazilian Oral Research 34, e005, 2020
152020
The influence of systemic inflammation response index on survival outcomes of limited‐stage small‐cell lung cancer patients treated with concurrent Chemoradiotherapy
A Kucuk, EE Ozkan, S Eskici Oztep, H Mertsoylu, B Pehlivan, U Selek, ...
Journal of Oncology 2020 (1), 8832145, 2020
122020
Evaluating the predictive value of quantec rectum tolerance dose suggestions on acute rectal toxicity in prostate carcinoma patients treated with IMRT
EE Ozkan, A Ozseven, ZAK Cerkesli
Reports of Practical Oncology & Radiotherapy 25 (1), 50-54, 2020
72020
The esophageal dose–volume parameters for predicting Grade I–II acute esophagitis correlated with weight loss and serum albumin decrease in lung cancer radiotherapy
ZAK Cerkesli, EE Ozkan, A Ozseven
Journal of Cancer Research and Therapeutics 17 (1), 94-98, 2021
62021
Dosimetric evaluation of field-in-field and slidingwindow IMRT in endometrium cancer patients with a new approach for the conformity index
A Özseven, EE Özkan
International Journal of Radiation Research 18 (4), 853-862, 2020
62020
The role of Ga-68 PSMA PET/CT scan on differentiating of oligometastatic and high risk prostate cancer
M Erdoğan, EE Özkan, SA Öztürk, M Yıldız, SS Şengül
Molecular Imaging and Radionuclide Therapy 29 (3), 98, 2020
62020
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
A Kucuk, E Topkan, EE Ozkan, D Ozturk, B Pehlivan, U Selek
International Journal of Immunopathology and Pharmacology 37, 03946320231187759, 2023
42023
Mismatch repair mutations: Biomarker for immunotherapy in colorectal cancers
S Shenoy
Indian Journal of Cancer 60 (3), 415-417, 2023
32023
The Association of Death Anxiety, Loneliness, and Hopelessness with Clinical Features and Qualityof Life in Palliative Radiotherapy Patients.
ZA KAYMAK, G ÖZDAMAR ÜNAL, EE ÖZKAN
Turkish Journal of Oncology/Türk Onkoloji Dergisi 37 (3), 2022
32022
Impact of diabetes on gastrointestinal and urinary toxicity after radiotherapy for gynecologic malignancy
EE Özkan, E Erdemoğlu, J Raoufi
Turkish Journal of Obstetrics and Gynecology 16 (4), 260, 2019
32019
Evre IB-III Serviks Kanserinde Definitif ve Adjuvan Radyoterapi Sonuçlarının Karşılaştırmalı Değerlendirilmesi
ZA KAYMAK, EE ÖZKAN
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7 (2), 117-122, 2020
22020
Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers
J Raoufi, SC İşcan, C Hanedan, EE Özkan, SS Çerçi, E Erdemoğlu, ...
Turkish Journal of Obstetrics and Gynecology 15 (2), 99, 2018
22018
Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002)
HC Yıldırım, FÖ Dinçbaş, V Demircan, M Beyzadeoğlu, E Tekçe, G Yazıcı, ...
Strahlentherapie und Onkologie 200 (2), 143-150, 2024
12024
High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer
E Topkan, A Kucuk, EE Ozkan, D Ozturk, AA Besen, H Mertsoylu, ...
Discover Oncology 14 (1), 230, 2023
12023
The prognostic value of decrease in prognostic nutritional index in stage III non-small cell lung cancer patients during curative thoracic radiotherapy
ZA Kaymak, EE Ozkan
Indian Journal of Cancer 60 (1), 18-23, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20